Estrogen receptor transcription and transactivation: Basic aspects of estrogen action
暂无分享,去创建一个
[1] L. A. Miasnikov,et al. [Estrogens and atherosclerosis]. , 1965, Kardiologiia.
[2] R. Lindsay,et al. LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGEN EVIDENCE FOR AN INCREASED BONE MASS AFTER DELAYED ONSET OF ŒSTROGEN TREATMENT , 1976, The Lancet.
[3] H. Bush,et al. Breast Cancer Research , 1978, British Journal of Cancer.
[4] J. Shine,et al. Sequence and expression of human estrogen receptor complementary DNA. , 1986, Science.
[5] P. Argos,et al. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A , 1986, Nature.
[6] P. Ramwell,et al. Estradiol protects against experimental cardiac transplant atherosclerosis. , 1987, Transplantation proceedings.
[7] D. Sutherland,et al. Estradiol protects against experimental cardiac transplant atherosclerosis. , 1987 .
[8] J. Scheuer,et al. Effects of gonadectomy and hormonal replacement on rat hearts. , 1987, Circulation research.
[9] B. Komm,et al. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. , 1988, Science.
[10] R. Evans,et al. The steroid and thyroid hormone receptor superfamily. , 1988, Science.
[11] K. Mann,et al. Evidence of estrogen receptors in normal human osteoblast-like cells. , 1988, Science.
[12] N. Webster,et al. The human estrogen receptor has two independent nonacidic transcriptional activation functions , 1989, Cell.
[13] P. Chambon,et al. Role of the two activating domains of the oestrogen receptor in the cell‐type and promoter‐context dependent agonistic activity of the anti‐oestrogen 4‐hydroxytamoxifen. , 1990, The EMBO journal.
[14] C. Christiansen. Hormonal prevention and treatment of osteoporosis—State of the art 1990 , 1990, The Journal of Steroid Biochemistry and Molecular Biology.
[15] P. Buttrick,et al. Effects of sex hormones on development of physiological and pathological cardiac hypertrophy in male and female rats. , 1990, The American journal of physiology.
[16] L. Swanson,et al. Distribution of androgen and estrogen receptor mRNA‐containing cells in the rat brain: An in situ hybridization study , 1990, The Journal of comparative neurology.
[17] G A Colditz,et al. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. , 2004, Preventive medicine.
[18] G. Colditz,et al. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence☆☆☆ , 1991 .
[19] J. Lees,et al. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. , 1992, The EMBO journal.
[20] S Masood,et al. Estrogen and progesterone receptors in cytology: A comprehensive review , 1992, Diagnostic cytopathology.
[21] A. Folsom,et al. Association of Hormone-Replacement Therapy with Various Cardiovascular Risk Factors in Postmenopausal Women , 1993 .
[22] B. O’Malley,et al. Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. , 1993, Molecular endocrinology.
[23] W. McGuire,et al. Estrogen receptor mutations in breast cancer , 1993, Journal of cellular biochemistry.
[24] B. O’Malley,et al. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. , 1994, Annual review of biochemistry.
[25] R. Karas,et al. Estrogen and the blood vessel wall , 1994, Current opinion in cardiology.
[26] P. Ramwell,et al. Estradiol inhibition of arterial neointimal hyperplasia after balloon injury. , 1994, Journal of vascular surgery.
[27] Y. Ito,et al. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). , 1994, The Journal of clinical endocrinology and metabolism.
[28] B. Riggs,et al. Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[29] R. Karas,et al. Human vascular smooth muscle cells contain functional estrogen receptor. , 1994, Circulation.
[30] S. Cummings,et al. Estrogen Replacement Therapy and Fractures in Older Women , 1995, Annals of Internal Medicine.
[31] E. Simpson,et al. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. , 1995, The Journal of clinical endocrinology and metabolism.
[32] J. Pike,et al. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. , 1995, Molecular endocrinology.
[33] H. Gronemeyer,et al. Transcription factors 3: nuclear receptors. , 1995, Protein profile.
[34] L. Moore,et al. Estrogen, progesterone, and vascular reactivity: potential cellular mechanisms. , 1995, Endocrine reviews.
[35] B. Katzenellenbogen,et al. Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[36] M. Shupnik,et al. Estrogen regulates the expression of several different estrogen receptor mRNA isoforms in rat pituitary. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[37] S. Cummings,et al. Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group. , 1995, Annals of internal medicine.
[38] K. Umesono,et al. The nuclear receptor superfamily: The second decade , 1995, Cell.
[39] D. Vaughan,et al. Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. , 1996, Circulation.
[40] B. Katzenellenbogen,et al. Different Regions in Activation Function-1 of the Human Estrogen Receptor Required for Antiestrogen- and Estradiol-dependent Transcription Activation* , 1996, The Journal of Biological Chemistry.
[41] B. Katzenellenbogen,et al. Nuclear hormone receptors: ligand-activated regulators of transcription and diverse cell responses. , 1996, Chemistry & biology.
[42] R. Lichtman. Perimenopausal and postmenopausal hormone replacement therapy. Part 2. Hormonal regimens and complementary and alternative therapies. , 1996, Journal of nurse-midwifery.
[43] P. Ramwell,et al. Non-genomic effects of estrogen and the vessel wall. , 1996, Biochemical pharmacology.
[44] J. Polman,et al. ERβ: Identification and characterization of a novel human estrogen receptor , 1996 .
[45] B. Katzenellenbogen,et al. Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. , 1996, Molecular endocrinology.
[46] S. Hubchak,et al. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. , 1996, Circulation.
[47] R. Lichtman. Perimenopausal and postmenopausal hormone replacement therapy. Part 1. An update of the literature on benefits and risks. , 1996, Journal of nurse-midwifery.
[48] J. Gustafsson,et al. Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[49] S. Hilsenbeck,et al. Multiple splicing variants of the estrogen receptor are present in individual human breast tumors , 1996, The Journal of Steroid Biochemistry and Molecular Biology.
[50] P. Ramwell,et al. The vascular protective effects of estrogen , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[51] Andrzej M. Brzozowski,et al. Brzozowski, A M. et al. Molecular basis of agonism and antagonism in the estrogen receptor. Nature 389, 753-758 , 1997 .
[52] E. Resnick,et al. Specific modulation of estrogen receptor mRNA isoforms in rat pituitary throughout the estrous cycle and in response to steroid hormones , 1997, Molecular and Cellular Endocrinology.
[53] Helmut Dotzlaw,et al. Expression of estrogen receptor-beta in human breast tumors. , 1997, The Journal of clinical endocrinology and metabolism.
[54] H. Pols,et al. Differential Expression of Estrogen Receptors α and β mRNA During Differentiation of Human Osteoblast SV-HFO Cells. , 1997, Endocrinology.
[55] Y. Ouchi,et al. Estrogen inhibits cuff-induced intimal thickening of rat femoral artery: effects on migration and proliferation of vascular smooth muscle cells. , 1997, Atherosclerosis.
[56] E. Kalkhoven,et al. AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors , 1997, Molecular and cellular biology.
[57] P. Shughrue,et al. Comparative distribution of estrogen receptor‐α and ‐β mRNA in the rat central nervous system , 1997, The Journal of comparative neurology.
[58] G. Rubanyi,et al. Potential cellular signaling mechanisms mediating upregulation of endothelial nitric oxide production by estrogen. , 1997, Journal of vascular research.
[59] S. Nozawa,et al. Expression of Estrogen Receptor β in Rat Bone. , 1997, Endocrinology.
[60] J. Gaughan,et al. Expression of oestrogen receptor beta (ER beta) in multiple rat tissues visualised by immunohistochemistry. , 1997, The Journal of endocrinology.
[61] R. Karas,et al. Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. , 1997, Nature medicine.
[62] Zbigniew Dauter,et al. Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.
[63] L. Murphy,et al. Estrogen receptor variants and mutations , 1997, The Journal of Steroid Biochemistry and Molecular Biology.
[64] G. Jenster,et al. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. , 1997, Recent progress in hormone research.
[65] Eva Enmark,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Human Estrogen Receptor �-Gene Structure, Chromosomal Localization, and Expression Pattern* , 2022 .
[66] Eva Enmark,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Human Estrogen Receptor �-Gene Structure, Chromosomal Localization, and Expression Pattern* , 2022 .
[67] N. Wintfeld,et al. Postmenopausal hormone therapy and mortality. , 1997, The New England journal of medicine.
[68] R. Karas,et al. Cardiac myocytes and fibroblasts contain functional estrogen receptors 1 , 1997, FEBS letters.
[69] N. Copeland,et al. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta. , 1997, Molecular endocrinology.
[70] H. Dotzlaq. Expression of Estrogen Receptor- in Human Breast Tumors , 1997 .
[71] Julia A. Taylor,et al. Estrogen receptor mutations , 1998, Molecular and Cellular Endocrinology.
[72] B. Katzenellenbogen,et al. Transcription Activation by the Human Estrogen Receptor Subtype b ( ER b ) Studied with ER b and ER a Receptor Chimeras * , 1998 .
[73] B. Katzenellenbogen,et al. Transcription Activation by the Human Estrogen Receptor Subtypeβ (ERβ) Studied with ERβ and ERα Receptor Chimeras* *This work was supported by NIH Grants CA-18119 and CA-60514 (to B.S.K.). , 1998, Endocrinology.
[74] J. Gustafsson,et al. Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury. , 1998, Circulation research.
[75] Foegh Ml,et al. Cardiovascular effects of estrogen: inplications of the discovery of the estrogen receptor subtype β , 1998 .
[76] Eric P. Smith,et al. Pediatric Endocrinology Update: An Overview , 1998, Hormone Research in Paediatrics.
[77] M. Adams,et al. Coronary artery and cultured aortic smooth muscle cells express mRNA for both the classical estrogen receptor and the newly described estrogen receptor beta , 1998, The Journal of Steroid Biochemistry and Molecular Biology.
[78] M. Foegh,et al. Cardiovascular effects of estrogen: implications of the discovery of the estrogen receptor subtype beta. , 1998, Current opinion in nephrology and hypertension.
[79] J. Gustafsson,et al. Generation and reproductive phenotypes of mice lacking estrogen receptor b (gene targetingyestrogen actionyovaryyfolliculogenesisyfertility) , 1998 .
[80] Y. Ouchi,et al. Molecular cloning and characterization of human estrogen receptor βcx: A potential inhibitor of estrogen action in human , 1998 .
[81] C Labrie,et al. Expression and neuropeptidergic characterization of estrogen receptors (ERalpha and ERbeta) throughout the rat brain: anatomical evidence of distinct roles of each subtype. , 1998, Journal of neurobiology.
[82] C. Grohé,et al. Expression of oestrogen receptor alpha and beta in rat heart: role of local oestrogen synthesis. , 1998, The Journal of endocrinology.
[83] J. Blaustein,et al. Induction of Progestin Receptors by Estradiol in the Forebrain of Estrogen Receptor-α Gene-Disrupted Mice , 1998, Journal of Neuroscience.
[84] R J Fletterick,et al. Structure and specificity of nuclear receptor-coactivator interactions. , 1998, Genes & development.
[85] O. Ylikorkala,et al. Estrogen and postmenopausal estrogen/progestin therapy: effect on endothelium-dependent prostacyclin, nitric oxide and endothelin-1 production. , 1998, European journal of obstetrics, gynecology, and reproductive biology.
[86] J. Gustafsson,et al. The Estrogen Receptor β Subtype: A Novel Mediator of Estrogen Action in Neuroendocrine Systems , 1998, Frontiers in Neuroendocrinology.
[87] S. Rosenkranz,et al. Estrogen modulates AT1 receptor gene expression in vitro and in vivo. , 1998, Circulation.
[88] P. Koza-Taylor,et al. Identification of Estrogen Receptor β2, A Functional Variant of Estrogen Receptor β Expressed in Normal Rat Tissues. , 1998, Endocrinology.
[89] R J Fletterick,et al. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. , 1998, Science.
[90] N. Ben-Jonathan,et al. Cellular Distribution and Gene Regulation of Estrogen Receptorsα and β in the Rat Pituitary Gland. , 1998, Endocrinology.
[91] J. Gustafsson,et al. Differential Response of Estrogen Receptor a and Estrogen Receptor b to Partial Estrogen Agonists/Antagonists , 1998 .
[92] E. Levin,et al. Oestrogen and progesterone inhibit the stimulated production of endothelin-1. , 1998, The Biochemical journal.
[93] G. Prins,et al. Estrogen receptor‐β: Implications for the prostate gland , 1999 .
[94] B. Riggs,et al. The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. , 1999, Molecular endocrinology.
[95] R. Karas,et al. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. , 1999, The Journal of clinical investigation.
[96] Takashi Suzuki,et al. Messenger ribonucleic acid in situ hybridization analysis of estrogen receptors α and β in human breast carcinoma , 1999 .
[97] R. Latorre,et al. Acute Activation of Maxi-K Channels (hSlo) by Estradiol Binding to the β Subunit , 1999 .
[98] H Grøn,et al. Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[99] Helmut Dotzlaw,et al. Estrogen receptor-beta messenger RNA expression in human breast tumor biopsies: relationship to steroid receptor status and regulation by progestins. , 1999, Cancer research.
[100] Biologically Active Estrogen Receptor-β: Evidence from in Vivo Autoradiographic Studies with Estrogen Receptor α-Knockout Mice. , 1999, Endocrinology.
[101] Valerie Speirs,et al. Coexpression of Estrogen Receptor α and β: Poor Prognostic Factors in Human Breast Cancer? , 1999 .
[102] Helmut Dotzlaw,et al. Expression of estrogen receptor beta1, beta2, and beta5 messenger RNAs in human breast tissue. , 1999, Cancer research.
[103] R. Santen,et al. Alternatives to the use of estrogen in postmenopausal women. , 1999, Endocrine reviews.
[104] D. Lacey,et al. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. , 1999, Endocrinology.
[105] M. Yancisin,et al. Functional analysis of a novel estrogen receptor-beta isoform. , 1999, Molecular endocrinology.
[106] R. Karas,et al. The protective effects of estrogen on the cardiovascular system. , 2002, The New England journal of medicine.
[107] V. Giguère,et al. Orphan nuclear receptors: from gene to function. , 1999 .
[108] B. McEwen,et al. Estrogen actions in the central nervous system. , 1999, Endocrine reviews.
[109] C. Grohé,et al. Differential effects of 17[3‐estradiol on mitogen‐activated protein kinase pathways in rat cardiomyocytes , 1999, FEBS letters.
[110] J. Gustafsson,et al. Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[111] M. Parker,et al. Molecular Determinants of the Estrogen Receptor-Coactivator Interface , 1999, Molecular and Cellular Biology.
[112] K. Korach,et al. Estrogen receptor null mice: what have we learned and where will they lead us? , 1999, Endocrine reviews.
[113] M Carlquist,et al. Structure of the ligand‐binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist , 1999, The EMBO journal.
[114] J. Gustafsson,et al. Differential expression of estrogen receptors α and β in adult rat accessory sex glands and lower urinary tract , 2000, Molecular and Cellular Endocrinology.
[115] J. Gustafsson,et al. Estrogen receptors α and β in the rodent mammary gland , 2000, Breast Cancer Research.
[116] J. Gustafsson,et al. Cloning of a novel estrogen receptor expressed in rat prostate and ovary , 2022 .